Ascendis Pharma A/S
ASNDBiotechnology
$253.00+1.38%As of Oct 29vs prior close
- Market cap
- $16.6B
- P/E (TTM)
- –
- From 52W high
- −8.72%
- EPS (YE25)
- -€3.76
- Revenue (YE25)
- €720.1M
- Net margin
- -31.67%
- Dividend yield
- 0.00%
Nomior Score
57
Steady ProfileTop 32% of the scored universe
Growth—
Quality59
Value—
Momentum61
Resilience55
Growth
+75.30%revenue a year over 9 fiscal years
YE16 €4.6MYE25 €720.1M
Connections
Revenue to profitYE25
The operating loss was 19% of revenue, narrower by 58 pts on a year.